Both authors contributed equally.
Obesity in asthma: more neutrophilic inflammation as a possible explanation for a reduced treatment response
Article first published online: 12 JUN 2012
© 2012 John Wiley & Sons A/S
Volume 67, Issue 8, pages 1060–1068, August 2012
How to Cite
Telenga ED, Tideman SW, Kerstjens HAM, ten Hacken NHT, Timens W, Postma DS, van den Berge M. Obesity in asthma: more neutrophilic inflammation as a possible explanation for a reduced treatment response. Allergy 2012; DOI:10.1111/j.1398-9995.2012.02855.x.
Edited by: Hans-Uwe Simon
- Issue published online: 12 JUL 2012
- Article first published online: 12 JUN 2012
- Manuscript Accepted: 5 MAY 2012
|all2855-sup-0001-FigS1.jpg||image/jpg||462K||Figure S1. Flow chart of study 1.|
|all2855-sup-0002-FigS2.jpg||image/jpg||1141K||Figure S2. Monovariate correlation between baseline sputum neutrophils and change in FEV1 %predicted with corticosteroid treatment.|
|all2855-sup-0003-Onlinesupplement.doc||Word document||132K||Table S1. Baseline characteristics of obese (BMI ≥ 30 kg/m2) and lean (BMI < 25 kg/m2) patients in men and women. Table S2. Baseline characteristics for obese and nonobese patients. Table S3. Baseline characteristics of obese (BMI ≥ 30 kg/m2) and lean (BMI < 25 kg/m2) patients without current-smokers. Table S4. Associations between corticosteroid treatment response and BMI. Table S5. Changes with corticosteroid treatment in obese and nonobese patients. Table S6. Changes with corticosteroid treatment in obese (BMI ≥ 30 kg/m2) and lean (BMI < 25 kg/m2) patients without smokers. Appendix S1: Study design of study 1.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.